Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 12, 2022 Filed Dec 15, 2022 00:37 UTC |
Wolfe PeterChief Financial Officer
|
GrantStock Options (right to buy) · Derivative | 39,708 | $0.00 Strike: $11.58 | $0.00 |
DisclosureSEC source: 0001493152-22-035487 · ownership.xml · derivative · entry 4 Wolfe Peter · CIK 0001954398 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,708 Underlying: Common Stock · 39,708 shares Expires 2029-04-02 F4 · derivative.exercise_date: 100% of the option is immediately exercisable. The option vested in 3 equal annual installments commencing on April 2, 2020. Read SEC document |
| December 12, 2022 Filed Dec 15, 2022 00:37 UTC |
Wolfe PeterChief Financial Officer
|
GrantStock Options (right to buy) · Derivative | 9,927 | $0.00 Strike: $5.09 | $0.00 |
DisclosureSEC source: 0001493152-22-035487 · ownership.xml · derivative · entry 3 Wolfe Peter · CIK 0001954398 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,927 Underlying: Common Stock · 9,927 shares Expires 2027-10-30 F3 · derivative.exercise_date: 100% of the option is immediately exercisable. The option vested in 4 equal annual installments commencing on October 30, 2017. Read SEC document |
| December 12, 2022 Filed Dec 15, 2022 00:37 UTC |
Wolfe PeterChief Financial Officer
|
GrantStock Options (right to buy) · Derivative | 9,927 | $0.00 Strike: $5.09 | $0.00 |
DisclosureSEC source: 0001493152-22-035487 · ownership.xml · derivative · entry 2 Wolfe Peter · CIK 0001954398 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,927 Underlying: Common Stock · 9,927 shares Expires 2025-10-21 F2 · derivative.exercise_date: 100% of the option is immediately exercisable. The option vested in 3 equal annual installments commencing on October 21, 2016. Read SEC document |
| December 12, 2022 Filed Dec 15, 2022 00:37 UTC |
Wolfe PeterChief Financial Officer
|
GrantCommon Stock | 41,585 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-22-035487 · ownership.xml · nonDerivative · entry 1 Wolfe Peter · CIK 0001954398 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,585 F1 · price: Received in connection with the Issuer's business combination with Larkspur Health Acquisition Corp., a Delaware corporation ("Larkspur") in accordance with the terms of the Business Combination Agreement, dated July 20, 2022, as amended (the "Business Combination Agreement") by and among ZyVersa Therapeutics, Inc., a Florida corporation ("Old ZyVersa"), the Securityholder Representative (as defined in the Business Combination Agreement) named therein, Larkspur, and Larkspur Merger Sub, Inc., a Delaware corporation and a direct, wholly owned subsidiary of Larkspur ("Merger Sub") pursuant to which Merger Sub merged with and into Old ZyVersa (the "Acquisition Merger"), with Old Zyversa as the surviving company of the Acquisition Merger and, after giving effecting to such Acquisition Merger, Old ZyVersa became a wholly-owned subsidiary of Larkspur and changed its name to the Issuer. Read SEC document |
| December 12, 2022 Filed Dec 15, 2022 00:34 UTC |
Park Min-ChulDirector
|
GrantStock Options (right to buy) · Derivative | 9,927 | $0.00 Strike: $16.36 | $0.00 |
DisclosureSEC source: 0001493152-22-035485 · ownership.xml · derivative · entry 2 Park Min-Chul · CIK 0001956022 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,927 Underlying: Common Stock · 9,927 shares Expires 2032-01-28 F2 · derivative.exercise_date: The option vests in 3 equal annual installments commencing on January 28, 2023. Read SEC document |
| December 12, 2022 Filed Dec 15, 2022 00:34 UTC |
Park Min-ChulDirector
|
GrantStock Options (right to buy) · Derivative | 29,781 | $0.00 Strike: $16.36 | $0.00 |
DisclosureSEC source: 0001493152-22-035485 · ownership.xml · derivative · entry 1 Park Min-Chul · CIK 0001956022 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,781 Underlying: Common Stock · 29,781 shares Expires 2031-07-01 F1 · derivative.exercise_date: 100% of the option is immediately exercisable. The option vested on July 1, 2021. Read SEC document |
| December 12, 2022 Filed Dec 15, 2022 00:27 UTC |
Cashmere Karen A.Chief Commercial Officer
|
GrantStock Options (right to buy) · Derivative | 21,840 | $0.00 Strike: $16.36 | $0.00 |
DisclosureSEC source: 0001493152-22-035481 · ownership.xml · derivative · entry 5 Cashmere Karen A. · CIK 0001954546 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,840 Underlying: Common Stock · 21,840 shares Expires 2032-01-28 F5 · derivative.exercise_date: The option vests in 3 equal annual installments commencing on January 28, 2023. Read SEC document |
| December 12, 2022 Filed Dec 15, 2022 00:27 UTC |
Cashmere Karen A.Chief Commercial Officer
|
GrantStock Options (right to buy) · Derivative | 21,840 | $0.00 Strike: $16.36 | $0.00 |
DisclosureSEC source: 0001493152-22-035481 · ownership.xml · derivative · entry 4 Cashmere Karen A. · CIK 0001954546 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,840 Underlying: Common Stock · 21,840 shares Expires 2031-02-08 F4 · derivative.exercise_date: The option vests in 3 equal annual installments commencing on February 8, 2022. Read SEC document |
| December 12, 2022 Filed Dec 15, 2022 00:27 UTC |
Cashmere Karen A.Chief Commercial Officer
|
GrantStock Options (right to buy) · Derivative | 29,781 | $0.00 Strike: $11.58 | $0.00 |
DisclosureSEC source: 0001493152-22-035481 · ownership.xml · derivative · entry 3 Cashmere Karen A. · CIK 0001954546 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,781 Underlying: Common Stock · 29,781 shares Expires 2029-04-02 F3 · derivative.exercise_date: 100% of the option is immediately exercisable. The option vested in 3 equal annual installments commencing on April 2, 2020. Read SEC document |
| December 12, 2022 Filed Dec 15, 2022 00:27 UTC |
Cashmere Karen A.Chief Commercial Officer
|
GrantStock Options (right to buy) · Derivative | 19,854 | $0.00 Strike: $5.03 | $0.00 |
DisclosureSEC source: 0001493152-22-035481 · ownership.xml · derivative · entry 2 Cashmere Karen A. · CIK 0001954546 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,854 Underlying: Common Stock · 19,854 shares Expires 2027-10-30 F2 · derivative.exercise_date: 100% of the option is immediately exercisable. The option vested in 4 equal annual installments commencing on October 30, 2017. Read SEC document |
| December 12, 2022 Filed Dec 15, 2022 00:27 UTC |
Cashmere Karen A.Chief Commercial Officer
|
GrantStock Options (right to buy) · Derivative | 9,927 | $0.00 Strike: $5.03 | $0.00 |
DisclosureSEC source: 0001493152-22-035481 · ownership.xml · derivative · entry 1 Cashmere Karen A. · CIK 0001954546 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,927 Underlying: Common Stock · 9,927 shares Expires 2024-09-10 F1 · derivative.exercise_date: 100% of the option is immediately exercisable. The option vested in 3 equal annual installments commencing on September 10, 2014. Read SEC document |
| December 12, 2022 Filed Dec 16, 2022 21:41 UTC |
INCON Co., Ltd.10% owner
|
GrantWarrant (right to buy) · Derivative | 450,702 | $0.00 Strike: $6.90 | $0.00 |
DisclosureSEC source: 0001493152-22-035808 · ownership.xml · derivative · entry 2 INCON Co., Ltd. · CIK 0001958829 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 450,702 Underlying: Common Stock · 450,702 shares Expires 2027-12-12 F1 · derivative.exercise_date: The warrant is immediately exercisable in full. Read SEC document |
| December 12, 2022 Filed Dec 16, 2022 21:41 UTC |
INCON Co., Ltd.10% owner
|
GrantCommon Stock | 1,497,199 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-22-035808 · ownership.xml · nonDerivative · entry 1 INCON Co., Ltd. · CIK 0001958829 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,497,199 Read SEC document |
| March 08, 2022 Filed Mar 8, 2022 13:51 UTC | OtherClass B Common Stock | 3,427 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-016941 · doc4.xml · nonDerivative · entry 1 A.G.P. / ALLIANCE GLOBAL PARTNERS CORP. · CIK 0000318492 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 446,843 F1 · kind: Transfer of shares to certain investors for no consideration as contemplated in connection with Issuer's initial public offering because underwriters' over-allotment option was not fully exercised. Read SEC document |
|
| February 03, 2022 Filed Feb 7, 2022 19:36 UTC | OtherClass B Common Stock | 49,730 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-007614 · doc4.xml · nonDerivative · entry 1 A.G.P. / ALLIANCE GLOBAL PARTNERS CORP. · CIK 0000318492 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 450,270 F1 · kind: Cancellation of 49,730 shares ("Shares") of Issuer's Class B common stock as contemplated in connection with Issuer's initial public offering. Such Shares were forfeited and cancelled for no consideration because underwriters' over-allotment option was not fully exercised. Read SEC document |
|
| January 06, 2022 Filed Mar 10, 2022 17:30 UTC |
Skalicky GregoryDirector
|
OtherClass B common stock · Derivative | 953 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-011642 · ownership.xml · derivative · entry 1 Skalicky Gregory · CIK 0001878571 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,631 Underlying: Class A common stock · 953 shares Expires not disclosed F1 · security: As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date F1 · derivative.exercise_price: As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date F2 · kind: As contemplated in connection with the initial public offering of the Issuer, 953 shares of Class B common stock of the Issuer were forfeited for no consideration and cancelled because the underwriters of the Issuer's initial public offering did not exercise their over-allotment option in full, as described in the Issuer's Registration Statement. F1 · derivative.exercise_date: As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date F1 · derivative.expiration_date: As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date Read SEC document |
| January 06, 2022 Filed Mar 10, 2022 17:30 UTC |
Twitty ChristopherDirector
|
OtherClass B common stock · Derivative | 953 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-011643 · ownership.xml · derivative · entry 1 Twitty Christopher · CIK 0001870121 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,631 Underlying: Class A common stock · 953 shares Expires not disclosed F1 · security: As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date F1 · derivative.exercise_price: As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date F2 · kind: As contemplated in connection with the initial public offering of the Issuer, 953 shares of Class B common stock of the Issuer were forfeited for no consideration and cancelled because the underwriters of the Issuer's initial public offering did not exercise their over-allotment option in full, as described in the Issuer's Registration Statement. F1 · derivative.exercise_date: As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date F1 · derivative.expiration_date: As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date Read SEC document |
| January 06, 2022 Filed Mar 10, 2022 22:31 UTC |
O'Connor Daniel J.Director · Chief Executive Officer
|
OtherClass B common stock · Derivative | 609 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-011644 · ownership.xml · derivative · entry 3 O'Connor Daniel J. · CIK 0001376847 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 201,848 Underlying: Class A common stock · 609 shares Expires not disclosed F3 · security: As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date F3 · derivative.exercise_price: As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date F3 · kind: As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date F5 · shares: In connection with the partial exercise of the underwriters' over-allotment option, A.G.P./Alliance Global Partners transferred 3,427 shares to the Sponsor for no consideration. F3 · derivative.exercise_date: As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date F3 · derivative.expiration_date: As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date F2 · ownership.direct: The shares represent those owned by Mr. O'Connor, a member of Larkspur Health LLC based on his pro rata share of ownership of Larkspur Health LLC. Read SEC document |
| January 06, 2022 Filed Mar 10, 2022 22:31 UTC |
O'Connor Daniel J.Director · Chief Executive Officer
|
OtherClass B common stock · Derivative | 23,404 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-011644 · ownership.xml · derivative · entry 2 O'Connor Daniel J. · CIK 0001376847 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 201,239 Underlying: Class A common stock · 23,404 shares Expires not disclosed F3 · security: As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date F3 · derivative.exercise_price: As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date F3 · kind: As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date F4 · shares: As contemplated in connection with the initial public offering of the Issuer, 22,343 shares of Class B common stock of the Issuer were forfeited for no consideration and cancelled because the underwriters of the Issuer's initial public offering did not exercise their over-allotment option in full, as described in the Issuer's Registration Statement. F3 · derivative.exercise_date: As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date F3 · derivative.expiration_date: As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date F2 · ownership.direct: The shares represent those owned by Mr. O'Connor, a member of Larkspur Health LLC based on his pro rata share of ownership of Larkspur Health LLC. Read SEC document |
| January 06, 2022 Filed Mar 10, 2022 22:31 UTC |
O'Connor Daniel J.Director · Chief Executive Officer
|
OtherClass A Common Stock | 42,005 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-011644 · ownership.xml · nonDerivative · entry 1 O'Connor Daniel J. · CIK 0001376847 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 42,005 F1 · security: These shares are underlying units (each unit consisting of one share of Class A common stock and three-fourths of one warrant, each whole warrant exercisable to purchase one share of Class A common stock) acquired in a private placement by the Larkspur Health LLC (the "Sponsor") in connection with the issuer's initial public offering and subsequent partial exercise of the underwriters' over-allotment option. The above refers to the shares of Class A common stock included in the units purchased. F1 · kind: These shares are underlying units (each unit consisting of one share of Class A common stock and three-fourths of one warrant, each whole warrant exercisable to purchase one share of Class A common stock) acquired in a private placement by the Larkspur Health LLC (the "Sponsor") in connection with the issuer's initial public offering and subsequent partial exercise of the underwriters' over-allotment option. The above refers to the shares of Class A common stock included in the units purchased. F2 · ownership.nature: The shares represent those owned by Mr. O'Connor, a member of Larkspur Health LLC based on his pro rata share of ownership of Larkspur Health LLC. Read SEC document |
| January 06, 2022 Filed Mar 10, 2022 17:30 UTC |
Briones David S.Director · Chief Financial Officer
|
OtherClass B common stock · Derivative | 91 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-011641 · ownership.xml · derivative · entry 3 Briones David S. · CIK 0001599831 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · see footnote Disclosed balance after: 56,123 Underlying: Class A common stock · 156 shares Expires not disclosed F3 · security: As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date F3 · derivative.exercise_price: As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date F3 · kind: As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date F5 · shares: In connection with the partial exercise of the underwriters' over-allotment option, A.G.P./Alliance Global Partners transferred 3,427 shares to the Sponsor for no consideration. F3 · derivative.exercise_date: As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date F3 · derivative.expiration_date: As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date F2 · ownership.direct: The shares represent those owned by Mr. Briones, a member of Larkspur Health LLC based on his pro rata share of ownership of Larkspur Health LLC. Read SEC document |
| January 06, 2022 Filed Mar 10, 2022 17:30 UTC |
Briones David S.Director · Chief Financial Officer
|
OtherClass B common stock · Derivative | 1,533 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-011641 · ownership.xml · derivative · entry 2 Briones David S. · CIK 0001599831 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · see footnote Disclosed balance after: 55,967 Underlying: Class A common stock · 1,533 shares Expires not disclosed F3 · security: As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date F3 · derivative.exercise_price: As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date F3 · kind: As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date F4 · shares: As contemplated in connection with the initial public offering of the Issuer, 22,343 shares of Class B common stock of the Issuer were forfeited for no consideration and cancelled because the underwriters of the Issuer's initial public offering did not exercise their over-allotment option in full, as described in the Issuer's Registration Statement. F3 · derivative.exercise_date: As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date F3 · derivative.expiration_date: As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date F2 · ownership.direct: The shares represent those owned by Mr. Briones, a member of Larkspur Health LLC based on his pro rata share of ownership of Larkspur Health LLC. Read SEC document |
| January 06, 2022 Filed Mar 10, 2022 17:30 UTC |
Briones David S.Director · Chief Financial Officer
|
OtherClass A Common Stock | 10,752 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-011641 · ownership.xml · nonDerivative · entry 1 Briones David S. · CIK 0001599831 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · see footnote Disclosed balance after: 10,752 F1 · security: These shares are underlying units (each unit consisting of one share of Class A common stock and three-fourths of one warrant, each whole warrant exercisable to purchase one share of Class A common stock) acquired in a private placement by the Larkspur Health LLC (the "Sponsor") in connection with the issuer's initial public offering and subsequent partial exercise of the underwriters' over-allotment option. The above refers to the shares of Class A common stock included in the units purchased. F1 · kind: These shares are underlying units (each unit consisting of one share of Class A common stock and three-fourths of one warrant, each whole warrant exercisable to purchase one share of Class A common stock) acquired in a private placement by the Larkspur Health LLC (the "Sponsor") in connection with the issuer's initial public offering and subsequent partial exercise of the underwriters' over-allotment option. The above refers to the shares of Class A common stock included in the units purchased. F2 · ownership.nature: The shares represent those owned by Mr. Briones, a member of Larkspur Health LLC based on his pro rata share of ownership of Larkspur Health LLC. Read SEC document |
| January 06, 2022 Filed Mar 10, 2022 17:32 UTC |
Mehra RajDirector
|
OtherClass B common stock · Derivative | 953 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-011645 · ownership.xml · derivative · entry 1 Mehra Raj · CIK 0001757892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,631 Underlying: Class A common stock · 953 shares Expires not disclosed F1 · security: As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date F1 · derivative.exercise_price: As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date F2 · kind: As contemplated in connection with the initial public offering of the Issuer, 953 shares of Class B common stock of the Issuer were forfeited for no consideration and cancelled because the underwriters of the Issuer's initial public offering did not exercise their over-allotment option in full, as described in the Issuer's Registration Statement. F1 · derivative.exercise_date: As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date F1 · derivative.expiration_date: As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date Read SEC document |
| January 06, 2022 Filed Mar 10, 2022 22:32 UTC |
Larkspur Health LLC10% owner
|
OtherClass B Common Stock · Derivative | 3,427 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-011646 · ownership.xml · derivative · entry 2 Larkspur Health LLC · CIK 0001915818 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,141,326 Underlying: Class A Common Stock · 3,427 shares Expires not disclosed F2 · derivative.exercise_price: As described in the issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date F3 · kind: In connection with the partial exercise of the underwriters' over-allotment option, A.G.P./Alliance Global Partners transferred 3,427 shares to the reporting person for no consideration. F3 · shares: In connection with the partial exercise of the underwriters' over-allotment option, A.G.P./Alliance Global Partners transferred 3,427 shares to the reporting person for no consideration. F2 · derivative.exercise_date: As described in the issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date F2 · derivative.expiration_date: As described in the issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date Read SEC document |
| January 06, 2022 Filed Mar 10, 2022 22:32 UTC |
Larkspur Health LLC10% owner
|
OtherClass A Common Stock | 236,273 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-011646 · ownership.xml · nonDerivative · entry 1 Larkspur Health LLC · CIK 0001915818 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 236,273 F1 · kind: These shares are underlying units (each unit consisting of one share of Class A common stock and three-fourths of one warrant, each whole warrant exercisable to purchase one share of Class A common stock) acquired in a private placement by the Reporting Person in connection with the issuer's initial public offering and subsequent partial exercise of the underwriters' over-allotment option. The above refers to the shares of Class A common stock included in the units purchased. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.